128 related articles for article (PubMed ID: 9764140)
1. Effect of substance misuse in early psychosis.
Addington J; Addington D
Br J Psychiatry Suppl; 1998; 172(33):134-6. PubMed ID: 9764140
[TBL] [Abstract][Full Text] [Related]
2. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
3. Substance misuse at presentation to an early psychosis program.
Van Mastrigt S; Addington J; Addington D
Soc Psychiatry Psychiatr Epidemiol; 2004 Jan; 39(1):69-72. PubMed ID: 15022049
[TBL] [Abstract][Full Text] [Related]
4. Lifetime history of substance misuse in first-episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms.
Kamali M; McTigue O; Whitty P; Gervin M; Clarke M; Browne S; Larkin C; O'Callaghan E
Early Interv Psychiatry; 2009 Aug; 3(3):198-203. PubMed ID: 22640383
[TBL] [Abstract][Full Text] [Related]
5. Influence of spirituality and religiousness on substance misuse in patients with schizophrenia or schizo-affective disorder.
Huguelet P; Borras L; Gillieron C; Brandt PY; Mohr S
Subst Use Misuse; 2009; 44(4):502-13. PubMed ID: 19219658
[TBL] [Abstract][Full Text] [Related]
6. Substance misuse and early psychosis.
Tucker P
Australas Psychiatry; 2009 Aug; 17(4):291-4. PubMed ID: 19301164
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of substance misuse among individuals with severe mental illness in São Paulo.
Rossi Menezes P; Ratto LR
Soc Psychiatry Psychiatr Epidemiol; 2004 Mar; 39(3):212-7. PubMed ID: 14999454
[TBL] [Abstract][Full Text] [Related]
8. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
9. Management of schizophrenia with substance use disorders.
Lybrand J; Caroff S
Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
[TBL] [Abstract][Full Text] [Related]
10. Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories.
Iyer SN; Boekestyn L; Cassidy CM; King S; Joober R; Malla AK
Psychol Med; 2008 Aug; 38(8):1147-56. PubMed ID: 18366823
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
12. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric comorbidity in first episode schizophrenia: a 2 year, longitudinal outcome study.
Sim K; Chua TH; Chan YH; Mahendran R; Chong SA
J Psychiatr Res; 2006 Oct; 40(7):656-63. PubMed ID: 16904688
[TBL] [Abstract][Full Text] [Related]
14. A brief motivational intervention for substance misuse in recent-onset psychosis.
Kavanagh DJ; Young R; White A; Saunders JB; Wallis J; Shockley N; Jenner L; Clair A
Drug Alcohol Rev; 2004 Jun; 23(2):151-5. PubMed ID: 15370020
[TBL] [Abstract][Full Text] [Related]
15. Psychotic symptoms, self-harm and violence in individuals with schizophrenia and substance misuse problems.
Haddock G; Eisner E; Davies G; Coupe N; Barrowclough C
Schizophr Res; 2013 Dec; 151(1-3):215-20. PubMed ID: 24268935
[TBL] [Abstract][Full Text] [Related]
16. Auditing first episode psychosis: giving meaning to clinical governance.
Rowlands RP
Int J Clin Pract; 2001 Dec; 55(10):669-72. PubMed ID: 11777290
[TBL] [Abstract][Full Text] [Related]
17. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
18. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study.
Addington J; Addington D
Acta Psychiatr Scand; 2007 Apr; 115(4):304-9. PubMed ID: 17355521
[TBL] [Abstract][Full Text] [Related]
19. Substance misuse over the first 18 months of specialized intervention for first episode psychosis.
Carr JA; Norman RM; Manchanda R
Early Interv Psychiatry; 2009 Aug; 3(3):221-5. PubMed ID: 22640386
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients.
Herman M
Int J Ment Health Nurs; 2004 Dec; 13(4):282-91. PubMed ID: 15660598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
